Boston Scientific Launches Trial To Evaluate Neurostimulation For Treatment Of Chronic Migraine (via PR Newswire)First Patient Treated in OPTIMISE Clinical Trial Evaluating Safety, Efficacy of Occipital Nerve Stimulation Using Precision™ System NATICK, Mass., July 19, 2013 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has launched a clinical trial…
published: July 22, 2013 in: Boston Scientific, Clinical Studies/Trials, Neuro